![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
A Volterra, D Trotti and G Racagni
Center of Neuropharmacology, University of Milan, Italy.
Reuptake of glutamate in astrocytes, a critical mechanism involved in the maintenance of physiological excitatory amino acid neurotransmission, is inhibited by both arachidonic acid (AA) and reactive oxygen species (ROS), via incompletely defined molecular mechanisms. Because ROS are generated during AA metabolism and AA can be released as a result of ROS-mediated phospholipase A2 activation, it seems likely that their effects on uptake are mediated by a common mechanism. However, here we show that rapid (10-min) uptake inhibitions by AA or by ROS generated by the xanthine plus xanthine oxidase (XO) reaction are selectively abolished by distinct agents; bovine serum albumin (BSA) acts only on AA, whereas the scavenger enzymes superoxide dismutase (SOD) and catalase (CAT) and the disulfide-reducing agent dithiothreitol (DTT) act only on ROS. Moreover, when added together, xanthine/XO and AA decrease uptake in a fully additive manner. In particular, the effect of xanthine/XO is seen also in the presence of maximal AA inhibition. No major signs of cell damage or chemical reaction between AA and radicals accompany their cumulative effects on uptake. Finally, uptake inhibition elicited by AA and xanthine/XO together is attenuated but not blocked by either BSA, DTT, or SOD/CAT individually, whereas it is fully blocked and substantially reversed by a combination of SOD/CAT and BSA or SOD/CAT, DTT, and BSA. Together, these data indicate that AA and ROS act on glial glutamate transport via distinct noninteracting mechanisms. Therefore, they could independently and additively contribute to the impairment of reuptake function, a phenomenon observed in pathological conditions such as ischemia/reperfusion injury.
This article has been cited by other articles:
|
|
 |
|
  A. R. Jayakumar, K. S. Panickar, Ch. R. K. Murthy, and M. D. Norenberg Oxidative stress and mitogen-activated protein kinase phosphorylation mediate ammonia-induced cell swelling and glutamate uptake inhibition in cultured astrocytes. J. Neurosci., May 3, 2006; 26(18): 4774 - 4784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Mollace, C. Muscoli, E. Masini, S. Cuzzocrea, and D. Salvemini Modulation of Prostaglandin Biosynthesis by Nitric Oxide and Nitric Oxide Donors Pharmacol. Rev., June 1, 2005; 57(2): 217 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Taylor and S. J. Hewett Potassium-evoked Glutamate Release Liberates Arachidonic Acid from Cortical Neurons J. Biol. Chem., November 8, 2002; 277(46): 43881 - 43887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. ANDERZHANOVA, K. S. RAYEVSKY, P. SARANSAARI, E. RIITAMAA, and S. S. OJA Effects of Acute Toxic Doses of Psychostimulants on Extracellular Levels of Excitatory Amino Acids and Taurine in Rats: Comparison of d-Amphetamine and Sydnocarb Ann. N.Y. Acad. Sci., June 1, 2002; 965(1): 193 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-S. Yuan, L. Dey, J.-T. Xie, and H. H. Aung Pharmacology and toxicology of astrocyte-neuron glutamate transport and cycling. J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 1 - 6. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Smith, V. Haroutunian, K. L. Davis, and J. H. Meador-Woodruff Expression of Excitatory Amino Acid Transporter Transcripts in the Thalamus of Subjects With Schizophrenia Am J Psychiatry, September 1, 2001; 158(9): 1393 - 1399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-N. Billaud, C. Ly, T. R. Phillips, and J. C. de la Torre Borna Disease Virus Persistence Causes Inhibition of Glutamate Uptake by Feline Primary Cortical Astrocytes J. Virol., November 15, 2000; 74(22): 10438 - 10446. [Abstract] [Full Text]
|
|
|
|
|
|
S. L. Ingram and S. G. Amara Arachidonic Acid Stimulates a Novel Cocaine-Sensitive Cation Conductance Associated with the Human Dopamine Transporter J. Neurosci., January 15, 2000; 20(2): 550 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Lipton Ischemic Cell Death in Brain Neurons Physiol Rev, October 1, 1999; 79(4): 1431 - 1568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Slotboom, W. N. Konings, and J. S. Lolkema Structural Features of the Glutamate Transporter Family Microbiol. Mol. Biol. Rev., June 1, 1999; 63(2): 293 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. W. Perry, J. A. Hamilton, L. W. Tjoelker, G. Dbaibo, K. A. Dzenko, L. G. Epstein, Y. Hannun, J. S. Whittaker, S. Dewhurst, and H. A. Gelbard Platelet-activating Factor Receptor Activation. AN INITIATOR STEP IN HIV-1 NEUROPATHOGENESIS J. Biol. Chem., July 10, 1998; 273(28): 17660 - 17664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Gegelashvili and A. Schousboe High Affinity Glutamate Transporters: Regulation of Expression and Activity Mol. Pharmacol., July 1, 1997; 52(1): 6 - 15. [Abstract] [Full Text]
|
|
|
|
|
|
S. M. Fine, R. A. Angel, S. W. Perry, L. G. Epstein, J. D. Rothstein, S. Dewhurst, and H. A. Gelbard Tumor Necrosis Factor alpha Inhibits Glutamate Uptake by Primary Human Astrocytes. IMPLICATIONS FOR PATHOGENESIS OF HIV-1 DEMENTIA J. Biol. Chem., June 28, 1996; 271(26): 15303 - 15306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Trotti, A. Volterra, K. P. Lehre, D. Rossi, O. Gjesdal, G. Racagni, and N. C. Danbolt Arachidonic Acid Inhibits a Purified and Reconstituted Glutamate Transporter Directly from the Water Phase and Not via the Phospholipid Membrane J. Biol. Chem., April 28, 1995; 270(17): 9890 - 9895. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
